Baxter International | BAX - Operating Profit


Baxter International reported $276M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.24B 190M Jun/2026
Cooper Companies USD -31M 243.8M Mar/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Globus Medical USD 164M 17.31M Mar/2026
Halozyme Therapeutics USD -61.77M 26.64M Mar/2026
ICU Medical USD 30.38M 4.29M Mar/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
J&J USD 7.48B 860M Jun/2026
Laboratory Of America USD 456.7M 46.6M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Quest Diagnostics USD 459M 60M Jun/2026
Smith & Nephew USD 505M 65M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -17.43M 25.73M Mar/2026
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026